Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCL635 in Healthy Participants and Postmenopausal Women With Vasomotor Symptoms
NCT07118891Phase 2Active, not recruiting
- Sponsor
- AbCellera Biologics
- Start
- Jun 2025
- Primary completion
- Feb 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ABCL635 in menopause, sponsored by AbCellera Biologics. Started Jun 2025; status: active, not recruiting.
02
Drugs
ABCL635
03
Conditions
menopause
Beyond the preview
Go deeper on NCT07118891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07118891.